1762-41-0Relevant articles and documents
Strongly blue luminescent cationic iridium(III) complexes with an electron-rich ancillary ligand: Evaluation of their optoelectronic and electrochemiluminescence properties
Ladouceur, Sebastien,Swanick, Kalen N.,Gallagher-Duval, Shawn,Ding, Zhifeng,Zysman-Colman, Eli
, p. 5329 - 5343 (2013)
Two strongly blue luminescent cationic heteroleptic iridium complexes 1b and 2b bearing a 4,4′-bis(dimethylamino)-2,2′-bipyridine (dmabpy) ancillary ligand and either 1-benzyl-4-(2,4-difluorophenyl)-1H-1,2,3-triazole (dFphtl) or 2-(2,4-difluorophenyl)-5-methylpyridine (dFMeppyH), respectively, have been synthesized and fully characterized. In comparison with other analogues, the interplay of the triazole unit with the dmabpy unit and methylation of the pyridine ring are discussed with respect to the photophysical, electrochemical, and electrochemiluminescent (ECL) properties of the complexes. The two complexes, 1b and 2b, are blue emitters with λmax = 495 and 494 nm, respectively. The nature of the excited states was established by various photophysical and photochemical experiments as well as DFT calculations. Both complexes emit from a ligand-centered state, however, the emission of 1b possesses significant charge-transfer character, which is absent in 2b. The presence of the methyl group on the cyclometalating ligand leads only to a modest increase in the radiative rate constant, k r, but otherwise does not appreciably influence the optoelectronic properties of the complex compared with the non-methylated analogue. In contrast, the efficacy of the ECL emission when scanning to 2.50 V is strongly influenced by the presence of the methyl group. ECL emission is also enhanced in complexes bearing dmabpy ancillary ligands compared with those containing dtBubpy ligands. The two complexes exhibit similar electrochemical behavior. Incorporation of the dmabpy ligand shifts both the oxidation and reduction cathodically. The combination of the dmabpy and dFphtl groups increases the redox potential difference and thus the HOMO-LUMO gap but the emission is not further blueshifted. Thus, the structural modification of the cyclometalating ligand, although only modestly tuning the emission energy, modulates the nature of the excited state and the efficiency of the ECL process. The synthesis, photophysical, electrochemical, and electrochemiluminescent properties of two highly emissive cationic blue-emitting Ir complexes are reported. Variation of the ligand results in a change in the nature of the emission. The decoration on both the cyclometalating and ancillary ligands strongly influences the ECL efficiencies. A detailed DFT/TDDFT study corroborates experiment. Copyright
Novel di- and tetra(pyrazolyl)bipyridine ligands and their Co (II)-complexes for electrochemical applications
Zavozin, Alexander G.,Simirskaya, Nina I.,Nelyubina, Yulia V.,Zlotin, Sergei G.
, p. 7552 - 7556 (2016)
Novel di- and tetra(pyrazolyl)bipyridine ligands have been prepared from available bipyridine N-oxide and N,N′-dioxide nitro derivatives via nucleophilic substitution reactions. The ligands were converted to the corresponding homoleptic octahedral cobalt
Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A
Zhou, Qingqing,Reekie, Tristan A.,Abbassi, Ramzi H.,Indurthi Venkata, Dinesh,Font, Josep S.,Ryan, Renae M.,Munoz, Lenka,Kassiou, Michael
, p. 5852 - 5869 (2018/11/10)
Dual-specificity tyrosine phosphorylation-related kinase 1A (DYRK1A) is a dual-specificity protein kinase that catalyses phosphorylation and autophosphorylation. Higher DYRK1A expression correlates with cancer, in particular glioblastoma present within the brain. We report here the synthesis and biological evaluation of new heterocyclic diphenolic derivatives designed as novel DYRK1A inhibitors. The generation of these heterocycles such as benzimidazole, imidazole, naphthyridine, pyrazole-pyridines, bipyridine, and triazolopyrazines was made based on the structural modification of the lead DANDY and tested for their ability to inhibit DYRK1A. None of these derivatives showed significant DYRK1A inhibition but provide valuable knowledge around the importance of the 7-azaindole moiety. These data will be of use for developing further structure-activity relationship studies to improve the selective inhibition of DYRK1A.
